Search research articles
Contact Us
Filters
Showing results (461-470 of 477) with videos related to
Page
of 48
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2018
MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype
Emilie Plantamura, Amiran Dzutsev, Mathias Chamaillard, et al.
Neurobiology of Aging
|
August 29, 2012
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker
Kunie Ando, Pierre Dourlen, Anne-Véronique Sambo, et al.
Gynecologic Oncology
|
November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
Emiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Cancer Immunology, Immunotherapy : CII
|
December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII
|
August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Analytical Chemistry
|
June 23, 2026
NMR of Fully and Partially <sup>13</sup>C-Enriched Biomass Enhances Pendent Group Structural Characterization
John Ralph, Guy Lippens, Marco Tonelli, et al.
Nature Communications
|
September 24, 2015
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain, Nathalie Hennuyer, Damien Bosc, et al.
Biomarker Research
|
April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
Arnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Nature
|
December 27, 2016
The role of fatty acid β-oxidation in lymphangiogenesis
Brian W Wong, Xingwu Wang, Annalisa Zecchin, et al.
Nature Communications
|
July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference material
Edward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 477) with videos related to
Sort By:
Page
of 48
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2018
MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype
Emilie Plantamura, Amiran Dzutsev, Mathias Chamaillard, et al.
Neurobiology of Aging
|
August 29, 2012
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker
Kunie Ando, Pierre Dourlen, Anne-Véronique Sambo, et al.
Gynecologic Oncology
|
November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
Emiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Cancer Immunology, Immunotherapy : CII
|
December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII
|
August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Analytical Chemistry
|
June 23, 2026
NMR of Fully and Partially <sup>13</sup>C-Enriched Biomass Enhances Pendent Group Structural Characterization
John Ralph, Guy Lippens, Marco Tonelli, et al.
Nature Communications
|
September 24, 2015
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain, Nathalie Hennuyer, Damien Bosc, et al.
Biomarker Research
|
April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
Arnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Nature
|
December 27, 2016
The role of fatty acid β-oxidation in lymphangiogenesis
Brian W Wong, Xingwu Wang, Annalisa Zecchin, et al.
Nature Communications
|
July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference material
Edward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
Page
of 48